Pharnext
USPTO PatentsView assignee record - 47 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Pharnext ranks #7,060 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 7 technology areas.
- #7,060
- of 49,997 US assignees by volume
- 42nd percentile
- by Innovation Score (32.7/100)
- 15.0
- avg claims per patent
- -56%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R7060 · Foreign Corporation #7,060 · 47 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 47 grants
- UPPER-Q #7,060/49,997
- PHOTO-FINISH Nyxoah
- CPC-NARROW A61K · 7 areas
- INNOV-THIN 32.7/100
- CLAIMS-RICH 15.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -56% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Nyxoah SA (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Pharnext’s 32.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Pharnext
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Autumnpaper · near 33
Autumnpaper · near
33 score
- Corsair Pharma · near 33
Corsair Pharma · near
33 score
- Implus Footcare · near 33
Implus Footcare · near
33 score
- Pharnext · this assignee 33
Pharnext · this assignee
33 score
- Smartvue · near 33
Smartvue · near
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Pharnext's Innovation Score is 32.7/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Pharnext?
Each dot is one of Pharnext’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Pharnext’s own 15.0 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Pharnext's grants concentrate
Pharnext is a focused PatentsView assignee: 7 CPC subclasses with 97.9% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2019 (10 grants) versus a trough of 1 in 2022. By volume, Pharnext sits between Nyxoah SA and Pivot Medical, Inc..
Pharnext's three-year grant acceleration
From 2019–2021 to 2022–2024, Pharnext moved from 21 to 3 grants (0.14x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Pharnext's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nyxoah
Nyxoah SA
47 patents
- Ospedale SAN Raff…
Ospedale SAN Raffaele S.R.L.
47 patents
- Optinose AS
OptiNose AS
47 patents
- Pfeiffer Vacuum
Pfeiffer Vacuum
47 patents
- Plaid
Plaid, Inc.
47 patents
- Profil Verbindung…
Profil Verbindungstechnik GmbH & Co. KG
47 patents
- Phoenix Industrie…
Phoenix Industries Pty Ltd
47 patents
- Pivot Medical
Pivot Medical, Inc.
47 patents
- Pharnext ◀
Pharnext
47 patents
What this shows Pharnext holds 47 patents at rank #7,059, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Pharnext
By rank, the assignees closest to #7,059 in granted patent volume.
- Nyxoah SA #7,055 · 47 patents
- Ospedale SAN Raffaele S.R.L. #7,056 · 47 patents
- OptiNose AS #7,057 · 47 patents
- Pfeiffer Vacuum #7,058 · 47 patents
- Plaid, Inc. #7,060 · 47 patents
- Profil Verbindungstechnik GmbH & Co. KG #7,061 · 47 patents
- Phoenix Industries Pty Ltd #7,062 · 47 patents
- Pivot Medical, Inc. #7,063 · 47 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Pharnext's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Pharnext, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Pharnext ranks #487 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (33 here).
Pharnext's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 42nd percentile higher than 42% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 4.3% |
| 2016 | 7 | 14.9% |
| 2017 | 6 | 12.8% |
| 2018 | 7 | 14.9% |
| 2019 | 10 | 21.3% |
| 2020 | 8 | 17.0% |
| 2021 | 3 | 6.4% |
| 2022 | 1 | 2.1% |
| 2023 | 2 | 4.3% |
| 2025partial year | 1 | 2.1% |
Which technologies does Pharnext patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Pharnext's patent record in context - here's where to go next.
- Pharnext's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 97.9% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #7,060 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Pharnext against Nyxoah SA, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.